With the current operating strategy for phase II they need 30-40 people with a UTI to recruit and be treated. Stratify them into different dosing regimes. Path tests of a few days after. Independent review panel review 3 months. All done inside 8 months.
Phase III studies are likely to be much bigger, but seriously if you have sepsis secondary to a UTI you are dying without prompt effective treatment. You will take the treatment. If you are alive 3 days later the treatment worked. No long follow up. Lets say recruitment takes a year you are still done inside 18 months.
On top of this they will need probably another 6-9 months for the FDA to agree on trial design. Still on track.
Ann: R327 added to WHO List of Antibacterial Products, page-20
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.5¢ |
Change
-0.020(3.36%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 58.0¢ | 57.5¢ | $13.44K | 23.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 143 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 4749 | 2 |
View Market Depth
| Last trade - 15.57pm 21/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |